Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;15(1):33-6.

Liposomes as Advanced Delivery Systems for Nutraceuticals

Christopher W Shade  1
Affiliations

Liposomes as Advanced Delivery Systems for Nutraceuticals

Christopher W Shade. Integr Med (Encinitas). 2016 Mar.

Abstract

Liposomes are delivery vehicles for transporting substances into the body effectively via facilitating absorption directly in the mouth or by preventing breakdown by stomach acid. Since the 1970s, liposomes have been investigated as potential drug delivery systems because of their biocompatibility and ability to incorporate both hydrophilic and hydrophobic therapeutic agents. Despite early promise, it was decades later, in the late 1990s to the present, that liposome technologies could create successful commercial products. Oral deliveries are recently emerging as availability of quality phospholipids and reliable homogenization and sizing equipment have become routinely available. Nutritional industry use of liposomes will grow rapidly in the next 5-10 y. High-quality products with more complex mixtures of pure compounds and complex botanical mixtures will offer clinicians less-invasive options for dosing and delivery of these actives.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nanoemulsion: Phospholipid Monolayer Encloses a Liquid Lipid Core
Figure 2
Figure 2
Liposome: Phospholipid Bilayer Enclosing an Aqueous Core
See this image and copyright information in PMC

References

    1. Bangham AD, Horne RW. Negative staining of phospholipids and their structural modification by surface-active agents as ovserved in the electron microscope. J Molec Biol. 1964;8(5):660–668. - PubMed
    1. Silva AC, Santos D, et al. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: Peroral and mucosal routes. Curr Med Chem. 2012;19(26):4495–4510. - PubMed
    1. Rogers JA, Anderson KE. The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15(5):421–480. - PubMed
    1. Patel HM, Ryman BE. Oral administration of insulin by encapsulation within liposomes. FEBS Letters. 1976;62(1):60–63. - PubMed
    1. Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Intern J Pharmaceutics. 1997;154(2):123–140.

LinkOut - more resources